Latham & Watkins Advises SoftBank Vision Fund 2 In Forward Health’s US$225 million Series D Financing

An emerging companies team advises a lead investor in the funding of the subscription based health care analytics and preventative case service.

April 29, 2021

Forward Health, a healthcare system empowering doctors with technology and data to monitor and guide long-term health, has announced US$225 million in Series D funding with participation from SoftBank Vision Fund 2. The funding will help expand Forward Health’s healthcare system nationwide and introduce new doctor-led programs focused on heart health, cancer detection, COVID-19, stress, anxiety, and weight management.

Latham & Watkins LLP represented SoftBank Vision Fund 2 in the transaction with an emerging companies team led by Bay Area partners Ben Potter and Saad Khanani, with Chicago associate Omar Ammash and Bay Area associate Adam Zuckerman. Advice was also provided on antitrust matters by Washington, D.C. counsel Patrick English; on data and technology transactions by Los Angeles counsel Jia Jia Huang, with associate Nicole Nour; and on data privacy matters by Bay Area counsel Robert Blamires, with Boston associate Kiara Vaughn.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.